HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis of biotinylated episilvestrol: highly selective targeting of the translation factors eIF4AI/II.

Abstract
Silvestrol (1) and episilvestrol (2) are protein synthesis inhibitors, and the former has shown efficacy in multiple mouse models of cancer; however, the selectivity of these potent cytotoxic natural products has not been described. Herein, it is demonstrated that eukaryotic initiation factors eIF4AI/II were the only proteins detected to bind silvestrol (1) and biotinylated episilvestrol (9) by affinity purification. Our study demonstrates the remarkable selectivity of these promising chemotherapeutics.
AuthorsJennifer M Chambers, Lisa M Lindqvist, Andrew Webb, David C S Huang, G Paul Savage, Mark A Rizzacasa
JournalOrganic letters (Org Lett) Vol. 15 Issue 6 Pg. 1406-9 (Mar 15 2013) ISSN: 1523-7052 [Electronic] United States
PMID23461621 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Protein Synthesis Inhibitors
  • Triterpenes
  • episilvestrol
  • silvestrol
  • Eukaryotic Initiation Factor-4A
Topics
  • Animals
  • Biotinylation
  • Eukaryotic Initiation Factor-4A (antagonists & inhibitors)
  • Humans
  • Mice
  • Protein Synthesis Inhibitors (chemistry, pharmacology)
  • Triterpenes (chemical synthesis, chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: